MalarVx
Don Foster, Ph.D., has been involved in the biotechnology, biopharmaceutical, drug discovery industry for over 30 years in roles including research scientist, Vice President of Research, Corporate Vice President, Chief Scientific Officer, and recently as a Portfolio Planning Consultant. He was involved in the Seattle start-up, Zymogenetics, and Implicit Biosciences.
Don was Vice President of Autoimmune Research for Novo Nordisk, a global healthcare company with markets in 180 countries. During 28 years in drug discovery, he has headed some of the most prolific discovery teams in the fields of immune-mediated diseases with a key role in the discovery and bringing forward six drugs in current clinical development, four marketed products (Zovant™, Cleactor™, Human Factor VII™, RecoThrom™), and is an inventor on 48 issued US patents. Dr. Foster earned his Ph.D. in the Department of Biochemistry at the University of Washington.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
MalarVx
MalarVx is a bio-pharmaceutical company located in the Center for Infectious Disease Research facility in Seattle, Washington. They founded MalarVx to address the myriad challenges of creating a safe, affordable, effective malaria vaccine using innovative new technologies discovered through research.